These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33894266)

  • 1. Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants.
    Relangi D; Somashekar S; Jain D; Vanbuskirk S; Bancalari E; Sosenko I; Claure N
    J Pediatr; 2021 Aug; 235():58-62. PubMed ID: 33894266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
    Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
    Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
    [No Abstract]   [Full Text] [Related]  

  • 4. Active versus restrictive ligation strategy for patent ductus arteriosus - A retrospective two-center study of extremely preterm infants born between 22 + 0 and 25 + 6 weeks of gestational age.
    Söderström F; Sindelar R; Olsson KW; Yousef S; Todorova D; Pestalozzi J; Mellander M; Raaijmakers R
    Early Hum Dev; 2024 Apr; 191():105976. PubMed ID: 38452632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
    Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
    JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants.
    Potsiurko S; Dobryanskyy D; Sekretar L; Salabay Z
    Am J Perinatol; 2024 Apr; 41(6):730-738. PubMed ID: 35213904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Extremely Premature Infants Comparing Patent Ductus Arteriosus Management Approaches.
    Altit G; Saeed S; Beltempo M; Claveau M; Lapointe A; Basso O
    J Pediatr; 2021 Aug; 235():49-57.e2. PubMed ID: 33864797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
    Woynarowska M; Rutkowska M; Szamotulska K
    Med Wieku Rozwoj; 2008; 12(4 Pt 1):933-41. PubMed ID: 19471069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of different patent ductus arteriosus treatment in preterm infants born between 28 and 32 weeks in Taiwan.
    Chung HW; Yang ST; Liang FW; Chen HL;
    Pediatr Neonatol; 2023 Jul; 64(4):411-419. PubMed ID: 36653283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
    Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
    Villamor E; van Westering-Kroon E; Gonzalez-Luis GE; Bartoš F; Abman SH; Huizing MJ
    JAMA Netw Open; 2023 Nov; 6(11):e2345299. PubMed ID: 38015504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus.
    Chock VY; Punn R; Oza A; Benitz WE; Van Meurs KP; Whittemore AS; Behzadian F; Silverman NH
    Pediatr Res; 2014 Apr; 75(4):570-5. PubMed ID: 24378897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
    Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
    Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical ligation, not transcatheter closure, associated with a higher severity of bronchopulmonary dysplasia in extremely preterm infant intervened for patent ductus arteriosus.
    Wei YJ; Ju YT; Hsieh ML; Kan CD; Lin YC; Wang JN
    Pediatr Pulmonol; 2023 Apr; 58(4):1221-1228. PubMed ID: 36696083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
    Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
    J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.
    Edstedt Bonamy AK; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M;
    Neonatology; 2017; 111(4):367-375. PubMed ID: 28125815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covariation of Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Management and In-Neonatal Intensive Care Unit Outcomes Following Preterm Birth.
    Hagadorn JI; Bennett MV; Brownell EA; Payton KSE; Benitz WE; Lee HC
    J Pediatr; 2018 Dec; 203():225-233.e1. PubMed ID: 30243544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
    Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
    J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.